BT Wealth Management’s Elevance Health ELV Stock Holding History

BT Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$359K	–	61
2021 Q1	$359K	Sell	1,000 -1,340	-57%	-$431K	0.12%	41
2020 Q4	$751K	Hold	2,340	–	–	0.28%	27
2020 Q3	$629K	Hold	2,340	–	–	0.27%	29
2020 Q2	$615K	Hold	2,340	–	–	0.31%	26
2020 Q1	$531K	Hold	2,340	–	–	0.3%	27
2019 Q4	$707K	Hold	2,340	–	–	0.36%	30
2019 Q3	$562K	Hold	2,340	–	–	0.31%	33
2019 Q2	$670K	Hold	2,340	–	–	0.39%	30
2019 Q1	$672K	Sell	2,340 -268	-10%	-$77.5K	0.4%	30
2018 Q4	$804K	Buy	+2,608	New	+$717K	0.35%	37

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BT Wealth Management's ELV Position: Q2 2021 in Review

BT Wealth Management sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 1,000 shares — an estimated $359K sold.

BT Wealth Management first reported a position in ELV in Q4 2018 and held it in 10 quarters. The position peaked at $804K in Q4 2018. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

BT Wealth Management reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
BT Wealth Management sold 1,000 Elevance Health shares in Q2 2021, an estimated $359K.
BT Wealth Management first reported a position in Elevance Health in Q4 2018 and held it in 10 quarters.
BT Wealth Management's Elevance Health position peaked at $804K in Q4 2018.
1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on BT Wealth Management's 13F filing for Q2 2021, filed 28 Jul 2021.